From the markers evaluated in a study with 83 participants (44 MDS, 20 healthy subjects and 19 patients with non-MDS conditions), CD61, CD36 and CD42a were found decreased and CD34 was asynchronously expressed within the MDS group (110). Here, GP9 is linked to myelodysplastic syndrome.